Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(76 sites)
United States
University of California Irvine Chao Family Comprehensive Cancer Center, Irvine, California University of San Diego Moores Cancer Center, La Jolla, California UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California USC Norris Comprehensive Cancer Center, Los Angeles, California Rocky Mountain Cancer Center, Denver, Colorado Yale Cancer Center, New Haven, Connecticut Medical Oncology Hematology Consultants, Newark, Delaware University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida Advent Health, Orlando, Florida Florida Cancer Specialists South, Port Charlotte, Florida Massachusetts General Hospital, Boston, Massachusetts Dana Farber Cancer Institute, Boston, Massachusetts Karmanos Cancer Institute, Detroit, Michigan Columbia University, New York, New York Memorial Sloan Kettering, New York, New York Duke University, Durham, North Carolina The Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio University of Oklahoma, Oklahoma City, Oklahoma Oregon Health & Science University (OHSU), Portland, Oregon Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania WellSpan York Cancer Center, York, Pennsylvania Medical University of South Carolina, Charleston, South Carolina Sarah Cannon Research Institute, Nashville, Tennessee New Experimental Therapeutics - NEXT Oncology, Austin, Texas UTSW - Moody Outpatient Center - Parkland Health, Dallas, Texas UT Southwest Simmons Cancer Center, Dallas, Texas The University of Texas MD Anderson Cancer Center, Houston, Texas New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio, Texas Virginia Cancer Specialists, Fairfax, Virginia University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington University of Wisconsin Carbone Cancer Center, Madison, Wisconsin Australia
Chris O'Brien Lifehouse Hospital, Camperdown, New South Wales Mater Cancer Care Centre, South Brisbane, Queensland Flinders Medical Center, Bedford Park, South Australia Monash Medical Centre, Clayton, Victoria Linear Clinical Research, Nedlands, Western Australia France
ICANS - Institut de cancérologie Strasbourg Europe, Strasbourg, Bas-Rhin Institut Bergonie, Bordeaux, Gironde Institut Claudius Regaud, Toulouse, Haute-Garonne EDOG Institut de Cancerologie de l'Ouest, Saint-Herblain, Loire-Atlantique Centre Jean Perrin, Clermont-Ferrand, Puy-de-Dôme Institut Gustave Roussy, Villejuif, Val-de-Marne Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer, Lyon Institute Cancer De Lorraine, Vandœuvre-lès-Nancy Germany
Nationale Centrum für Tumorerkrankungen (NCT) Heidelberg, Heidelberg, Baden-Wurttemberg Universitätsklinikum Augsburg, Augsburg, Bavaria Asklepios Klinik Altona, Hamburg, Free and Hanseatic City of Hamburg Universitätsklinikum Frankfurt, Frankfurt am Main, Hesse Universitätsklinikum Essen, Essen, North Rhine-Westphalia Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio Istituti Fisioterapici Ospitalieri - Istituto Nazionale Tumori Regina Elena, Rome, Lazio ASST Grande Ospedale Metropolitano Niguarda, Milan, Lombardy Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Lombardy Istituto Europeo Di Oncologia, Milan, Lombardy Istituto Clinico Humanitas, Rozzano, Lombardy Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo, Torino Humanitas San Pio X, Milan IRCCS - lstituto Nazionale Tumori - Fondazione G. Pascale, Naples Singapore
National University Hospital, Kent Ridge National Cancer Center of Singapore, Singapore South Korea
Asan Medical Center, Seoul National Cancer Center, Seoul Samsung Medical Center, Seoul Seoul University Hospital, Seoul Severance Hospital Yonsei University, Seoul Spain
START MADRID_Hospital Universitario Fundacion Jimenez Diaz, Madrid, Madrid START MADRID_Hospital Universitario HM Sanchinarro - CIOCC, Madrid, Madrid Instituto de Investigacion Oncologica Vall d'Hebron (VHIO) - EPON, Barcelona NEXT Oncology-Hospital Quironsalud Barcelona, Barcelona Hospital Universitario 12 de Octubre, Madrid Hospital Clinico Universitario de Valencia, Valencia United Kingdom
Sarah Cannon Research Institute UK, London, Middlesex Freeman Hospital, Newcastle upon Tyne, Tyne and Wear